Nifeviroc

尼非韦罗

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNifeviroc
Drug Alias NameTD-0232
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 5 antagonists
TargetsC-C chemokine receptor type 5
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesShanghai Targetdrug Co LtdShanghai Institute Of Organic ChemistryAvexa Ltd +[4] 
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesAvexa LtdShanghai Institute Of Organic ChemistryShanghai Targetdrug Co Ltd +[4] 
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A